Treatment of irritable bowel syndrome.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000178:diet therapy / Q000188:drug therapy*; D004043:Dietary Fiber / Q000627:therapeutic use; D004415:Dyspepsia / Q000188:drug therapy; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012841:Simethicone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004043:Dietary Fiber; D010276:Parasympatholytics; D011619:Psychotropic Drugs; D012841:Simethicone